The Cigna Group (CI) Revenue — Quarter Ended Sep 30, 2024
Total revenue increased for the quarter compared to both the prior quarter and the same period a year ago. Revenue growth was driven by higher pharmacy revenues, premiums, and fees and other revenues.
Key takeaway
Quarter ended Sep 30, 2024 · FY2024 Q3
Total revenue increased for the quarter compared to both the prior quarter and the same period a year ago. Revenue growth was driven by higher pharmacy revenues, premiums, and fees and other revenues.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$63.7B
Revenue reported for this quarter.
Quarter-over-quarter
+5.2%
Change from the immediately preceding quarter.
Year-over-year
+29.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$232.6B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2023 | $51.1B | +11.7% |
| Mar 31, 2024 | $57.3B | +23.1% |
| Jun 30, 2024 | $60.5B | +24.6% |
| Sep 30, 2024 | $63.7B | +29.9% |
Revenue performance
Reported total revenue rose relative to the immediately preceding quarter. The largest component, pharmacy revenues, increased sequentially, while premiums and fees also contributed to the gain.
Quarterly comparison
Revenue was significantly higher than the same quarter one year earlier, with pharmacy revenues showing a substantial increase. Premiums and fees also grew compared to the year-ago period.
What to watch
Net realized investment losses were reported, which reduced pre-tax income despite the revenue increase.